Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade

Amphastar Pharmaceuticals is a successful drugmaker with a wide range of drugs, showing strong stock performance and growth potential. It offers a diverse portfolio of medications, including innovative products like Baqsimi. With robust earnings and revenue growth, it is a top performer in the industry.